Literature DB >> 16480587

[Clinical analysis of 1,142 hospitalized cantonese patients with nasopharyngeal carcinoma].

Su-Mei Cao1, Xiang Guo, Ning-Wei Li, Yan-Qun Xiang, Ming-Huang Hong, Hua-Qing Min.   

Abstract

BACKGROUND &
OBJECTIVE: Few large-scale epidemiologic investigations of nasopharyngeal carcinoma (NPC) at high incidence region in Guangdong province were reported in recent 20 years. This study was to summarize clinical data of a population of hospitalized Cantonese NPC patients,analyze the epidemiologic characteristics of NPC in the high incidence region, and provide references for the prevention and treatment of NPC.
METHODS: Clinical data of 1 142 Cantonese NPC patients, hospitalized in Cancer Center of Sun Yat-sen University between Jan. 1998 and Aug. 2000, were collected according to well-designed forms and statistically analyzed.
RESULTS: The morbidity of NPC in Cantonese showed obvious family clustering: 21.9% of the patients had family history of cancer, and 12.3% had family history of NPC. Moreover, the family clustering feature was more obvious in the population from the region with higher incidence of NPC. The positive rate of VCA/IgA antibody was 90.0%, and that of EA/IgA antibody was 74.5%; the titers were positively related to tumor burden. Early diagnostic rate of NPC was about 30%.
CONCLUSIONS: NPC patients in Cantonese population have obvious family and territorial clustering. High positive rates of VCA/IgA and EA/IgA antibodies are helpful for early diagnosis of NPC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480587

Source DB:  PubMed          Journal:  Ai Zheng


  3 in total

1.  Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China.

Authors:  Su-Mei Cao; Sui-Hong Chen; Chao-Nan Qian; Qing Liu; Yun-Fei Xia
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

2.  Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Authors:  Ning Xue; Jian-Hua Lin; Shan Xing; Dan Liu; Shi-Bing Li; Yan-Zhen Lai; Xue-Ping Wang; Min-Jie Mao; Qian Zhong; Mu-Sheng Zeng; Wan-Li Liu
Journal:  Cancer Res Treat       Date:  2018-05-29       Impact factor: 4.679

3.  Nasopharyngeal carcinoma: A review of current updates.

Authors:  Lei Wu; Churong Li; Li Pan
Journal:  Exp Ther Med       Date:  2018-02-20       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.